{"id":"W3022175316","doi":"10.1038/s41388-020-1301-9","title":"Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma","year":2020,"lang":"en","type":"article","venue":"Oncogene","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Ontario Genomics; Ontario Ministry of Research, Innovation and Science; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Deutsche Forschungsgemeinschaft; Wellcome Trust; Novartis Pharma; Deutschen Konsortium für Translationale Krebsforschung; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Deutsche Krebshilfe; Pfizer","keywords":"BRD4; Bromodomain; BET inhibitor; Biology; Cancer research; Epigenetics; Oncogene; Acetylation; Histone; Cell cycle; Cancer; Molecular biology; Gene; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007424589,0.000248854,0.0003262818,0.0002410829,0.000110441,0.000177843,0.0002065215,0.0001838086,0.001102853],"category_scores_gemma":[0.00004297936,0.00007897874,0.00022941,0.0001587184,0.000111281,0.0001336337,0.0001539615,0.0004637701,0.0002145096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002489333,"about_ca_system_score_gemma":0.0002192122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005244763,"about_ca_topic_score_gemma":0.00156283,"domain_scores_codex":[0.9999619,0.000004678632,0.000003017515,0.000007488384,0.00001170472,0.0000112693],"domain_scores_gemma":[0.9999871,0.000002042198,0.00000324385,0.000001221203,0.000001991568,0.000004393963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004164394,0.0002397845,0.0003298867,0.0001694914,0.00002249513,0.0001660802,0.00001909759,0.0006752054,0.9761493,0.0002060926,0.0002886626,0.02131742],"study_design_scores_gemma":[0.0002760868,0.00268269,0.003873494,0.00001434348,0.0001033142,0.0005755846,0.00002727278,0.002475807,0.9807811,0.00009964302,0.009076568,0.00001412564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846688,0.007650192,0.004109461,0.0002341434,0.00004958781,0.000164422,0.0004523797,0.000143554,0.002527637],"genre_scores_gemma":[0.9935969,0.003075886,0.001660786,0.00006669535,0.00000918109,0.00004147342,0.0003701478,0.000009496653,0.001169451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001102853,"threshold_uncertainty_score":0.003689468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02589990274909979,"score_gpt":0.264227625750276,"score_spread":0.2383277230011762,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}